|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2002-5-31
|
|
pubmed:abstractText |
SAR studies aimed at improving the rate of clearance of a series of VLA-4 integrin antagonists by the introduction of a 1,3,5-triazine as an amide isostere are described.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0960-894X
|
|
pubmed:author |
pubmed-author:ArchibaldSarah CSC,
pubmed-author:BrownJulien AJA,
pubmed-author:ChildsKirstieK,
pubmed-author:CritchleyDavidD,
pubmed-author:HeadJohn CJC,
pubmed-author:HutchinsonBrianB,
pubmed-author:PartonTed A HTA,
pubmed-author:PorterJohn RJR,
pubmed-author:RobinsonMartyn KMK,
pubmed-author:ShockAnthonyA,
pubmed-author:WarrellowGraham JGJ,
pubmed-author:ZomayaAlexA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
17
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1591-4
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Discovery and evaluation of N-(triazin-1,3,5-yl) phenylalanine derivatives as VLA-4 integrin antagonists.
|
|
pubmed:affiliation |
Celltech R&D Ltd, 216 Bath Road, Slough SL1 4EN, UK. john.porter@celltechgroup.com
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
